TABLE 4.
Tetracyclines versus no tetracyclines | OR (95% CI) | p‐value |
---|---|---|
Visit type | ||
Ambulatory non‐dermatology | (Ref) | ‐ |
Ambulatory dermatology | 5.48 (1.19–25.26) | 0.03 |
Sex | ||
Female | (Ref) | ‐ |
Male | 0.13 (0.02–0.72) | 0.02 |
Age | 1.08 (0.99–1.18) | 0.08 |
Insurance type | ||
Private insurance | (Ref) | ‐ |
Medicare | 0.15 (0.02–1.15) | 0.07 |
Self‐pay | 6.62 (0.55–80.26) | 0.13 |
Medicaid | 0.24 (0.02–2.80) | 0.24 |
Other | 2.27 (0.13–38.98) | 0.56 |
Race | ||
White | (Ref) | ‐ |
Black | 0.82 (0.20–3.42) | 0.78 |
Hispanic | 0.34 (0.05–2.32) | 0.26 |
Other race | 3.60 (0.74–17.44) | 0.11 |
Charlson comorbidity index | 0.52 (0.14–2.01) | 0.33 |
Rural/Urban status | ||
Urban | (Ref) | ‐ |
Rural | 1.77 (0.07–46.17) | 0.72 |
F(12, 19) | 1.12 | |
Prob > F | 0.40 |